What are sympathetic nerve blocks for CRPS, and do they help?
A sympathetic nerve block is an injection of local anesthetic beside the sympathetic nerves in the neck or lower back that serve a limb with complex regional pain syndrome. Controlled trials have not shown that the injection relieves CRPS pain better than placebo. The 2022 practical guidelines call the role of the block "largely empiric."

What is a sympathetic nerve block?
A sympathetic nerve block is an injection of local anesthetic next to the chain of sympathetic nerves that runs along the spine. The 2022 practical guidelines in Pain Medicine describe two sites. For CRPS in an arm or hand, the injection is placed in the neck at the level of the sixth cervical vertebra, a procedure called a stellate ganglion block. For CRPS in a leg or foot, the injection is placed at the second and third lumbar vertebrae, a procedure called a lumbar sympathetic block. The guidelines state that the procedure is now usually performed with fluoroscopy, which is live X-ray guidance.
Why did doctors start using sympathetic blocks for CRPS?
Doctors began using sympathetic blocks because CRPS was once thought to be a disorder of an overactive sympathetic nervous system. CRPS type I was formerly called reflex sympathetic dystrophy (RSD), a name that reflects the theory. The 2022 practical guidelines record that sympathetic nerve blocks "were historically thought to be a necessary step" in managing CRPS pain, and the same guidelines call the underlying theory questionable. Clinicians once believed that at least one block was needed to sort patients into two groups: sympathetically maintained pain, which eased after a block, and sympathetically independent pain, which did not.
What did the placebo-controlled trials of sympathetic blocks find?
The placebo-controlled trials did not show that sympathetic blocks reduce CRPS pain. The 2016 Cochrane review by O'Connell and colleagues included 12 studies with 461 participants and judged every study to be at high or unclear risk of bias. Two small studies with 32 participants in total compared local anesthetic blocks with placebo or sham injections, and they "did not demonstrate significant short-term benefit."
The Cochrane authors concluded that "the limited data available do not suggest that LASB is effective for reducing pain in CRPS," using their abbreviation for local anesthetic sympathetic blockade. The 2023 Cochrane overview of CRPS treatments by Ferraro and colleagues reached the same reading. That overview found moderate-certainty evidence that a lidocaine sympathetic block "probably does not reduce pain intensity compared with placebo."
What did the Price 1998 saline study show?
The Price 1998 study showed that a saline injection relieved CRPS pain almost as much as local anesthetic did at its peak. Price and colleagues gave 7 CRPS patients two sympathetic blocks each, one with lidocaine and bupivacaine and one with saline, in a double-blind crossover design. Four patients had stellate ganglion blocks and three had lumbar sympathetic blocks.
Both injections produced large pain reductions in 6 of the 7 patients 30 minutes later. Peak relief averaged 68.7 percent after saline and 74.4 percent after local anesthetic, a difference that "did not approach statistical significance." Duration did differ. Relief lasted a mean of 19.9 hours after saline and 3 days 18 hours after local anesthetic. The study was small, and it remains the reason short-lived relief after a block is read with caution.
How do the studies of sympathetic blocks compare?
Four published sources carry most of the evidence on sympathetic nerve blocks for CRPS, and only two of them pooled randomized trials.
| Study | What it examined | What it reported |
|---|---|---|
| Price 1998, Clinical Journal of Pain | 7 CRPS patients given a saline block and a local anesthetic block | Peak relief 68.7 percent with saline and 74.4 percent with local anesthetic; anesthetic relief lasted longer |
| O'Connell 2016, Cochrane review | 12 randomized studies of sympathetic blocks, 461 participants | No significant short-term benefit over placebo in two small trials |
| Ferraro 2023, Cochrane overview | Systematic reviews of CRPS treatments | Lidocaine sympathetic block probably does not reduce pain compared with placebo, moderate certainty |
| Hassantash 2003, Archives of Surgery | 1,528 uncontrolled case reports of causalgia | Response to sympathetic blocks reported in 88 percent |
Does pain relief after a block prove that a person has CRPS?
No. Pain relief after a sympathetic block does not prove CRPS, and a block that fails does not rule CRPS out. Response to a block is not part of the Budapest criteria, which rest on symptoms and on signs found at the examination. The Price 1998 study found large early relief after saline alone.
The 2022 practical guidelines describe a group of 33 patients with CRPS type I in whom the rate of pain relief after a stellate ganglion block was little higher than 50 percent, even when the block fully interrupted sympathetic function. Insurers and defense examiners sometimes point to a failed block as evidence against the diagnosis. The diagnostic criteria do not support that use. How CRPS is diagnosed explains the criteria.
What do current guidelines say about sympathetic blocks?
Current guidelines treat sympathetic blocks as an optional aid to rehabilitation, not as a proven treatment. The 2022 practical guidelines state that "sympathetic nerve blocks lack high quality evidence to support a definitive role in the treatment of CRPS" and describe the blocks as "currently out of favor." The same guidelines add that blocks may matter for a subset of patients if they reduce pain and provide a less painful "window of opportunity" for rehabilitation.
The Royal College of Physicians' 2018 guideline notes that some centers inject local anesthetic at the sympathetic chain to aid physiotherapy. The guideline reports "no conclusive evidence for this practice from randomised controlled trials" and concludes that "more research is needed before these methods can be formally recommended."
What about guanethidine and other intravenous regional blocks?
Intravenous regional blocks with guanethidine have been tested and did not work. An intravenous regional block, also called a Bier block, delivers a drug into the veins of the affected limb while a tourniquet holds the drug in place. The Royal College of Physicians' 2018 guideline states that intravenous regional sympathetic blocks with guanethidine "should not be used routinely in the treatment of CRPS, as four randomised controlled trials have not demonstrated any benefit." The 2022 practical guidelines reviewed the same technique with several other drugs and concluded that "the evidence supporting efficacy" of intravenous regional anesthesia "is of low quality."
Are sympathetic blocks more effective in CRPS type II?
Older reports describe a high response to sympathetic blocks in CRPS type II, but none of the reports had a control group. CRPS type II was formerly called causalgia and follows an identified nerve injury. A 2003 analysis by Hassantash and colleagues pooled 110 articles describing 1,528 cases of causalgia. High-velocity missiles caused at least 77 percent of the injuries, and the articles reported a response to sympathetic blocks in 88 percent of cases. The pooled reports were case descriptions without placebo comparison, so the 88 percent figure cannot be compared with the controlled trials in CRPS type I.
What side effects have studies of sympathetic blocks reported?
The randomized studies of sympathetic blocks reported minor side effects, and the reporting was incomplete. Only six of the 12 studies in the 2016 Cochrane review recorded adverse events, "all with minor effects reported." The Cochrane authors wrote that "it is not possible to draw firm conclusions regarding the efficacy or safety of this intervention" from the existing evidence. The trials enrolled small numbers of patients, which limits what they can show about uncommon complications. A physician who performs the procedure is the source for the risks of a particular block in a particular patient.
Is anyone still studying sympathetic blocks for CRPS?
Yes. Researchers continue to register small studies of sympathetic blocks for CRPS. A Stanford University pilot trial, registered as NCT00637533, tested lumbar sympathetic blocks with botulinum toxin added and enrolled 10 participants. The 2022 practical guidelines summarize a study of that combination in 9 patients, in which the added toxin lengthened pain relief from a mean of 10 days to 71 days.
A trial at Ankara City Hospital in Turkey, registered as NCT07129811, is testing stellate ganglion blocks added to physical therapy in 32 people with CRPS after stroke. The registry listed that trial as recruiting when this page was checked. The CRPS clinical trial finder lists registered studies with California sites.
Common questions
Sources
Every source below was opened and read for this page. The date is when it was last checked.
- Complex Regional Pain Syndrome: Practical Diagnostic and Treatment Guidelines, 5th EditionClinical guideline · Pain Medicine (Harden et al.), 2022 · checked
- Complex regional pain syndrome in adults: UK guidelines for diagnosis, referral and management in primary and secondary care, 2nd editionClinical guideline · Royal College of Physicians, 2018 · checked
- Local anaesthetic sympathetic blockade for complex regional pain syndromeStudy · Cochrane Database of Systematic Reviews (O'Connell et al.), 2016 · checked
- Interventions for treating pain and disability in adults with complex regional pain syndrome: an overview of systematic reviewsStudy · Cochrane Database of Systematic Reviews (Ferraro et al.), 2023 · checked
- Analysis of peak magnitude and duration of analgesia produced by local anesthetics injected into sympathetic ganglia of complex regional pain syndrome patientsStudy · The Clinical Journal of Pain (Price et al.), 1998 · checked
- Causalgia: a meta-analysis of the literatureStudy · Archives of Surgery (Hassantash et al.), 2003 · checked
- Cervico-thoracic or lumbar sympathectomy for neuropathic pain and complex regional pain syndromeStudy · Cochrane Database of Systematic Reviews (Straube et al.), 2013 · checked
- A Pilot Clinical Trial of Sympathetic Blockade With Botulinum Toxin Type A to Treat Complex Regional Pain Syndrome (NCT00637533)Study · ClinicalTrials.gov (Stanford University) · checked
- Stellate Ganglion Block in Complex Regional Pain Syndrome (NCT07129811)Study · ClinicalTrials.gov (Ankara City Hospital Bilkent) · checked

CRPS treatment
How CRPS is diagnosed
CRPS clinical trial finder
Budapest criteria self-check